Venture
RefleXion Medical, Inc.
Latest Form D 2023-11-22- CIK 1604459
- Other Health Care
- 6 Form D offerings since 2014-04-04
- Total sold
- $413M
- across 6 offerings
- Rounds
- 6
- Form D offerings since 2014-04-04
- Latest round
- $107M
- 2023-11-22 · 021-498008
- Investors
- 43
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2023-11-22 · $107M
- 2014-04-04$6.1M021-214930
- 2016-04-19$23M021-261633
- 2018-04-02$96.5M021-309122
- 2020-04-17$100M021-365306
- 2022-03-16$80.7M021-437588
- 2023-11-22$107M021-498008
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($107M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-498008 | First filed2023-11-22 | Latest2023-11-22 | Sought$201M | Sold$107M | Investors43 | Exemptions506(b) |
| 021-437588 | First filed2022-03-16 | Latest2022-03-16 | Sought$110M | Sold$80.7M | Investors31 | Exemptions506(b) |
| 021-365306 | First filed2020-04-17 | Latest2020-04-17 | Sought$125M | Sold$100M | Investors17 | Exemptions506(b) |
| 021-309122 | First filed2018-04-02 | Latest2018-04-02 | Sought$103M | Sold$96.5M | Investors18 | Exemptions506(b) |
| 021-261633 | First filed2016-04-19 | Latest2016-04-19 | Sought$52M | Sold$23M | Investors5 | Exemptions506(b) |
| 021-214930 | First filed2014-04-04 | Latest2014-04-04 | Sought$11.6M | Sold$6.1M | Investors19 | Exemptions506(b) |
Who backs RefleXion Medical, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2023-11-22
| Name | Relationship |
|---|---|
| Todd Powell | RelationshipExecutive Officer, Director |
| Samuel Mazin | RelationshipExecutive Officer, Director |
| Jay Watkins | RelationshipDirector |
| Greg Garfield | RelationshipDirector |
| Fred Moll | RelationshipDirector |
| Matthew T. Hobart | RelationshipDirector |
| Cem Usakli | RelationshipDirector |
| Renee Ryan | RelationshipDirector |
| Rana Al-Hallaq | RelationshipDirector |
| Alice Schroeder | RelationshipDirector |
| Kevin Reilly | RelationshipDirector |
| Art Heidrich | RelationshipDirector |
| Martyn Webster | RelationshipExecutive Officer |
| Sean Shirvani | RelationshipExecutive Officer |
| David Larkin | RelationshipExecutive Officer |
| Jeffrey Holifield | RelationshipExecutive Officer |
| Philip J. Aulson II | RelationshipExecutive Officer |
| Judy Bartlett-Roberto | RelationshipExecutive Officer |
| Leena Kadakia | RelationshipExecutive Officer |
| Diana King | RelationshipExecutive Officer |
| Gopinath Kuduvalli | RelationshipExecutive Officer |
| Leonard Lyons | RelationshipExecutive Officer |
| Thorsten Melcher | RelationshipExecutive Officer |
| Kathy O'Shaughnessy | RelationshipExecutive Officer |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| BofA Securities, Inc. | CRD283942 | Broker-dealer— | Offerings1 |
| Morgan Stanley & Co. LLC | CRD8209 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- —
- Exemptions
- Rule 506(b)
- First filed
- 2014-04-04
- Latest filing
- 2023-11-22
Who backs RefleXion Medical, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗